Evidence-Based Medicine

Research Appraisals

Evidence-based critical appraisals of the latest medical research, systematically evaluated using Oxford CEBM methodology.

Showing 3 appraisals

Systematic ReviewEvidence: Moderate
65CEBM

Behavioural brain research

Neural correlates of rumination in psychiatric disorders: A systematic review of fMRI evidence

BACKGROUND: Rumination is a transdiagnostic, persistent factor across many psychiatric conditions. Mapping its neural mechanisms may help differentiate ruminative profiles. OBJECTIVE: To systematically review fMRI studies that evaluated rumination in psychiatric populations METHODS: We searched four databases (PubMed, EMBASE, Web of Science, Scopus) and included studies that integrated rumination measures with fMRI data. RESULTS: Thirty-two articles met criteria; most were non-randomized (n = 31, 97%) and focused on depression (n = 24, 75%). Across disorders, clinical groups showed higher rumination than healthy controls, including in euthymic participants. In major depressive disorder, neural alterations implicated the default mode network, limbic and striatal regions, dorsolateral prefrontal cortex, and anterior cingulate cortex consistent with maladaptive ongoing processing. Neural signatures often persisted in remitted patients, suggesting possible trait markers of vulnerability. Intervention studies (n = 7) support using neuroimaging to track ruminative profiles and to inform more personalized interventions. CONCLUSION: This review highlights the importance of examining rumination, here measured via trait questionnaires, state-induction paradigms, cognitive tasks, or resting-state fMRI, using more consistent conceptual and methodological approaches. Although rumination is transdiagnostic, implicated brain regions and networks may show disorder-specific patterns. Given heterogeneity in the literature, future work should prioritize controlled and interventional studies to clarify neural mechanisms and guide circuit-based, targeted treatments. PROSPERO REGISTRATION: #CRD532512.

7 June 2026

Read appraisal →
observationalEvidence: Weak
50CEBM

Psychiatry research

A machine learning approach to predicting clinical trajectories in bipolar disorder

BACKGROUND: Bipolar disorder (BD) is characterized by significant heterogeneity in clinical presentation, age of onset, and diagnostic delays. Identifying clinical trajectories and subtypes is a central aim of precision psychiatry, with the goal of improving risk stratification and characterization of illness courses, enabling early recognition of high-risk patients and facilitating timely interventions that improve long-term outcomes. METHODS: This is a dual-site retrospective cross-sectional secondary analysis of 203 clinical datasets from BD patients to develop machine learning models: Random Forest, Weighted Logistic Regression (LR), and XGBoost, supplemented by statistical modelling, to predict age of onset timing (early/late onset) and illness severity. Survival analysis (Kaplan-Meier and Cox proportional hazards) investigated factors influencing diagnostic delay, while clustering identified patient subtypes. RESULTS: Single-split Weighted LR (AUC = 0.733) and nested cross-validation XGBoost (AUC = 0.729) achieved superior performance in predicting onset timing. Cluster analysis identified three distinct phenotypes: baseline low complexity, late-onset familial-severe, and an early-onset comorbid group. Survival analysis revealed that the time to diagnosis was independent of clinical risk profiles (Log-Rank p = 0.34), with the most severe cases experiencing significant diagnostic latency. CONCLUSIONS: Machine learning accurately predicts BD clinical trajectories using routinely collected data in an African cohort. Diagnostic delay did not differ significantly across clinical risk or severity strata, indicating that the measured variables did not explain variation in time to diagnosis.

4 May 2026

Read appraisal →
observationalEvidence: Weak
50CEBM

Journal of affective disorders

Exploring temperamental and clinical predictors of lithium treatment outcomes in bipolar disorder using diverse machine learning approaches

BACKGROUND: Lithium is a core treatment for bipolar disorder (BD), yet clinical response varies across patients. Testing accessible predictors of lithium response is critical for personalization strategies in real-world settings. METHODS: In this cross-sectional study, 179 individuals with BD were assessed using a broad range of standardized clinical instruments and the Brief TEMPS-M to evaluate affective temperaments. Lithium response was retrospectively classified via the Alda Scale. Multivariate linear regressions and three supervised machine learning classifiers (random forest, elastic net, and XGBoost) were applied to identify predictors of treatment response. Class imbalance was addressed by down-sampling during training. RESULTS: Responders (12.3 % of participants) were more likely to be employed, diagnosed with BD-II, had fewer lifetime depressive and hypomanic episodes, fewer suicide attempts, and significantly lower anxious temperament scores. In multivariable models, lifetime psychotic and mixed features, as well as higher counts of hypomanic and manic episodes, were independently associated with poorer lithium response. Machine learning models confirmed the importance of these variables, possibly with remarkably high predictive validity (random forest AUC = 1.00; elastic net and XGBoost F1 = 0.86). Hyperthymic temperament was positively associated with lithium response, whereas cyclothymic and depressive traits were associated with poorer lithium response. CONCLUSIONS: The present exploratory study should be intended as a primer for larger samples and more balanced replication studies employing reliable machine learning techniques, allowing for firm conclusions about suggestive clinical predictors of lithium response in BD, and their complex interaction.

16 Apr 2026

Read appraisal →